Biora Therapeutics granted extension to regain compliance with Nasdaq
Biora Therapeutics granted extension to regain compliance with Nasdaq Source: Seekingalpha
Biora Therapeutics granted extension to regain compliance with Nasdaq Source: Seekingalpha
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements Source: Seekingalpha